These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


169 related items for PubMed ID: 8313486

  • 1. Facts about once-a-month injectable contraceptives: memorandum from a WHO meeting.
    Bull World Health Organ; 1993; 71(6):677-89. PubMed ID: 8313486
    [Abstract] [Full Text] [Related]

  • 2. Pharmacodynamic effects of once-a-month combined injectable contraceptives.
    Sang GW.
    Contraception; 1994 Apr; 49(4):361-85. PubMed ID: 8013220
    [Abstract] [Full Text] [Related]

  • 3. Once-a-month injectable contraceptives: efficacy and reasons for discontinuation.
    Koetsawang S.
    Contraception; 1994 Apr; 49(4):387-98. PubMed ID: 8013221
    [Abstract] [Full Text] [Related]

  • 4. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given by intramuscular injection to Chinese women. II. The comparison of bleeding patterns.
    Sang GW, Shao QX, Ge RS, Ge JL, Chen JK, Song S, Fang KJ, He ML, Luo SY, Chen SF.
    Contraception; 1995 Mar; 51(3):185-92. PubMed ID: 7621686
    [Abstract] [Full Text] [Related]

  • 5. Vaginal bleeding patterns in women using once-a-month injectable contraceptives.
    Fraser IS.
    Contraception; 1994 Apr; 49(4):399-420. PubMed ID: 8013222
    [Abstract] [Full Text] [Related]

  • 6. A review of "once-a-month" combined injectable contraceptives.
    Newton JR, D'arcangues C, Hall PE.
    J Obstet Gynaecol (Lahore); 1994 Apr; 4 Suppl 1():S1-34. PubMed ID: 12290848
    [Abstract] [Full Text] [Related]

  • 7. Acceptability of the once-a-month injectable contraceptives Cyclofem and Mesigyna in Egypt.
    Hassan EO, el-Nahal N, el-Hussein M.
    Contraception; 1994 May; 49(5):469-88. PubMed ID: 8045133
    [Abstract] [Full Text] [Related]

  • 8. A multicentred phase III comparative clinical trial of Mesigyna, Cyclofem and Injectable No. 1 given monthly by intramuscular injection to Chinese women. I. Contraceptive efficacy and sid effects.
    Sang GW, Shao QX, Ge RS, Ge JL, Chen JK, Song S, Fang KJ, He ML, Luo SY, Chen SF.
    Contraception; 1995 Mar; 51(3):167-83. PubMed ID: 7621685
    [Abstract] [Full Text] [Related]

  • 9. A comparative study on the return to ovulation following chronic use of once-a-month injectable contraceptives.
    Bassol S, Hernandez C, Nava MP, Trujillo AM, Luz de la Cruz D.
    Contraception; 1995 May; 51(5):307-11. PubMed ID: 7628206
    [Abstract] [Full Text] [Related]

  • 10. Once-a-month injectable contraceptives.
    d'Arcangues C.
    World Health Forum; 1993 May; 14(4):439-40. PubMed ID: 8185807
    [Abstract] [Full Text] [Related]

  • 11. Existing once-a-month combined injectable contraceptives.
    Toppozada MK.
    Contraception; 1994 Apr; 49(4):293-301. PubMed ID: 8013216
    [Abstract] [Full Text] [Related]

  • 12. Once-a-month estrogen/progestogen injectables.
    D'arcangues C.
    Entre Nous Cph Den; 1991 Dec; (19):15. PubMed ID: 12222332
    [Abstract] [Full Text] [Related]

  • 13. Long-acting hormonal contraceptives for women.
    Garza-Flores J, Hall PE, Perez-Palacios G.
    J Steroid Biochem Mol Biol; 1991 Dec; 40(4-6):697-704. PubMed ID: 1958567
    [Abstract] [Full Text] [Related]

  • 14. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion.
    el Nahal N, Hassan EO, el Houssinie M.
    Contraception; 1999 Jun; 59(6):369-75. PubMed ID: 10518231
    [Abstract] [Full Text] [Related]

  • 15. Introduction of cyclofem once-a-month injectable contraceptive in Mexico.
    Garza-Flores J, Moraks del Olmo A, Fuziwara JL, Figueroa JG, Alonso A, Monroy J, Perez M, Urbina-Fuentes M, Guevara SJ, Cedeno E, Barrios R, Ferman JJ, Medina LM, Velazquez E, Perez-Palacios G.
    Contraception; 1998 Jul; 58(1):7-12. PubMed ID: 9743890
    [Abstract] [Full Text] [Related]

  • 16. Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
    Seibert B, Günzel P.
    Contraception; 1994 Apr; 49(4):303-33. PubMed ID: 8013217
    [Abstract] [Full Text] [Related]

  • 17. Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis.
    United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulaion.
    Contraception; 2003 Sep; 68(3):159-76. PubMed ID: 14561536
    [Abstract] [Full Text] [Related]

  • 18. Once-a-month injectable contraceptives, Cyclofem and Mesigyna, in Egypt. Efficacy, causes of discontinuation, and side effects.
    Hassan EO, el-Nahal N, el-Hussinie M.
    Contraception; 1999 Aug; 60(2):87-92. PubMed ID: 10592855
    [Abstract] [Full Text] [Related]

  • 19. Comparative study of the effects of two once-a-month injectable steroidal contraceptives (Mesigyna and Cyclofem) on lipid and lipoprotein metabolism. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank, Special Programme of Research, Development and Research Training in Human Reproduction.
    Contraception; 1997 Oct; 56(4):193-207. PubMed ID: 9408700
    [Abstract] [Full Text] [Related]

  • 20. New once-a-month injectable contraceptives, with particular reference to Cyclofem/Cyclo-Provera.
    Hall PE.
    Int J Gynaecol Obstet; 1998 Aug; 62 Suppl 1():S43-56. PubMed ID: 9806239
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.